(Q44043033)

29 November 2017

title

Development of level A, B and C in vitro-in vivo correlations for modified-release levosimendan capsules (English)

1 reference

29 November 2017

Kortejärvi H

1

1 reference

29 November 2017

Mikkola J

2

1 reference

29 November 2017

Bäckman M

3

1 reference

29 November 2017

Antila S

4

1 reference

29 November 2017

Marvola M

5

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

International Journal of Pharmaceutics

29 November 2017

published in

1 reference

29 November 2017

volume

241

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

87-95

1 reference

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900137-0

7 January 2021

Site dependent bioavailability and metabolism of levosimendan in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900137-0

7 January 2021

In vitro/in vivo correlations: scientific implications and standardisation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900137-0

7 January 2021

Correlation of ‘in vitro’ release and ‘in vivo’ absorption characteristics of four salbutamol sulphate formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900137-0

7 January 2021

Automated analysis of levosimendan in human plasma by on-line dialysis and liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900137-0

7 January 2021

Inotropic effects of OR-1896, an active metabolite of levosimendan, on canine ventricular myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900137-0

7 January 2021

KINETIC ANALYSIS OF BLOOD LEVELS AND URINARY EXCRETION IN THE ABSORPTIVE PHASE AFTER SINGLE DOSES OF DRUG

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900137-0

7 January 2021

Theophylline controlled-release formulations: in vivo-in vitro correlations.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900137-0

7 January 2021

10.1016/S0378-5173(02)00137-0

Identifiers

DOI

1 reference

29 November 2017

1 reference